The International Association for the Study of Lung Cancer Staging Project: Prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 13, Issue 1, 2010, Pages 9-18

  Chansky, Kari ^a   Sculier, Jean Paul ^b   Crowley, John J ^a   Giroux, Dori ^a   Meerbeeck, Jan Van ^c   Goldstraw, Peter ^d  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; CANCER SURGERY; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; PATHOLOGY; PROGNOSIS; REVIEW;

AGE FACTORS; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; SEX FACTORS;

EID: 75449106033     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2010.01.02     Document Type: Review

References (45)

1. Goldstraw P, Crowley JJ; On behalf of the IASLC International Staging Project. the international association for the study of lung cancer international staging project on lung cancer. J Thorac Oncol 2006;1: 281-286.
2. Rami-Porta R, Ball D, Crowley JJ, et al. International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC lung cancer staging project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007;2:593- 602.
3. Rusch VW, Crowley JJ, Giroux DJ, et al. International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2007;2:603- 612.
4. Postmus PE, Brambilla E, Chansky K, et al. International Association for the Study of Lung Cancer International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC lung cancer staging project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2007;2:686-693.
5. Goldstraw P, Crowley JJ, Chansky K, et al. International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;8:706 - 714.
6. Sculier JP, Chansky K, Crowley JJ, et al. International Staging Committee and Participating Institutions. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th edition of the TNM classification of malignant tumors and the proposals for the 7th edition. J Thorac Oncol 2008;3:457- 466.
7. Groome PA, Bolejack V, Crowley JJ, et al. IASLC International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC lung cancer staging project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:694 -705.
8. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. Histological Typing of Lung and Pleural Tumors, 3rd Ed. Berlin: Springer, 1999.
9. Crowley JJ, Leblanc M, Jacobson J, Salmon S. Some Exploratory Tools for Survival Analysis. In Lin DY, Fleming TR, (Eds.), New York: Springer, 1997.
10. Cancer Statistics Branch Surveillance Program DCCPS. The SEER Program Code Manual, 3rd Ed. Bethesda, MD: National Cancer Institute, National Institutes of Health, Public Health Service, U.S. Department of Health and Human Services, 1998.
11. Bianchi F, Nuciforo P, Vecchi M, et al. Survival prediction of stage I adenocarcinomas by expression of 10 genes. J Clin Invest 2007;117: 3436-3444.
12. Kawai H, Tada A, Kawahara M, et al. The Japan National Hospital Study Group for Lung Cancer. Smoking history before surgery and prognosis in patients with Stage IA non-small cell lung cancer-a multicenter study. Lung Cancer 2005;49:63-70.
13. Nordquist LT, Simon GR, Cantor A, Alberts M, Bepler G. Improved survival in never-smokers vs. current smokers with primary adenocarcinoma of the lung. Chest 2004;126:347-351.
14. Moro-Silot D, Aubert A, Diab S, et al. Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer. Eur Respir J 2005;26: 480-486.
15. Berardi R, Brunelli A, Tamburrano T, et al. Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for nonsmall cell lung cancer. Lung Cancer 2005;49:371-376.
16. Asamura H, Goya T, Koshiishi Y, et al. Japanese Joint Committee of Lung Cancer Registry. A Japanese lung cancer registry study. Prognosis of 13,010 resected lung cancers. J Thorac Oncol 2008;3:46-52.
17. Riquet M, Foucault C, Berna P, Assouad J, Dujon A, Danel C. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping. Ann Thorac Surg 2006;81:1988-1995.
18. Strand TE, Rostad H, Moller B, Norstein J. Survival aTheer resection for primary lung cancer: a population-based study of 3211 resected patients. Thorax 2006;61:710 -715.
19. Wisnivesky JP, Henschke C, McGinn T, Iannuzzi MC. Prognosis of stage II non-small cell lung cancer according to tumor and nodal status at diagnosis. Lung Cancer 2005;49:181-186.
20. Ferguson MK, Wang J, Hoffman PC, et al. Sex-associated differences in survival in patients undergoing resection for lung cancer. Ann Thorac Surg 2000;69:245-250.
21. Alexiou C, Onyeaka CV, Beggs D, et al. Do women live longer following lung resection for carcinoma? Eur J Cardiothorac Surg 2002;21:319 -325.
22. Ou SHI, Zell JA, Ziogas A, Anton-Culver H. Prognostic factors for survival of Stage I non-small cell lung cancer patients: a populationbased analysis of 19,702 Stage I patients in the California Cancer Registry from 1989-2003. Cancer 2007;110:1532-1541.
23. Sanchez de Cos J, Miravet L, Abal J, et al. Lung cancer survival in Spain and prognostic factors: a prospective, multiregional study. Lung Cancer 2008;59:246 -254.
24. Foegle J, Hedelin G, Lebitasy M, Purohit A, Velten M, Quoix E. Specific features of non-small cell lung cancer in women: a retrospective study of 1738 cases diagnosed in Bas-Rhin between 1982 and 1997. J Thorac Oncol 2007;2:466-474.
25. Caldarella A, Crocetti E, Comin CE, Janni A, Lopes Pegna A, Paci E. Gender differences in non-small cell lung cancer: a population study. Eur J Surg Oncol 2007;33:763-768.
26. Pfannschmidt J, Muley T, Bulzebruck H, Hoffman H, Dienemann H. Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2,083 patients. Lung Cancer 2007;55:371-377.
27. Madrekar SJ, Schild SE, Hillman SL, et al. A prognostic model for advanced stage non-small cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials. Cancer 2006;107:781-792.
28. Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 2002;122:1037-1057.
29. Raponi M, Zhang Y, Yu J, et al. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Res 2006;66:7466 -7472.
30. Raz DJ, Ray MR, Kim JY, et al. A multigene assay is prognostic of survival in patients with early stage lung adenocarcinoma. Clin Cancer Res 2008;14:5565-5570.
31. Sun Z, Wigle DA, Yang P. Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival. J Clin Oncol 2008;26:877- 883.
32. Lau SK, Boutros PC, Pintilie M, et al. Three-gene prognostic classifier for early-stage non-small cell lung cancer. J Clin Oncol 2007;25:5562-5569.
33. Skrzypski M, Jassem E, Taron M, et al. Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung. Clin Cancer Res 2008;14:4794-4799.
34. Shedden K, Taylor JM, Enkemann S, et al. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 2008;14:822- 827.
35. Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med 2008;359:1367-1380.
36. Greipp PR, San Miguel J, Durie BG, et al. International staging system for multiple myeloma. J Clin Oncol 2005;23:3412-3420.
37. Albain KS, Crowley JJ, Leblanc M, Livingston RB. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience. J Clin Oncol 1991;9:1618 -1626.
38. Albain KS, Crowley JJ, Leblanc M, Livingston RB. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group Database. J Clin Oncol 1990;8:1563-1574.
39. Yoshino I, Kawano D, Oba T, Yamazaki K, Kometani T, Maehara Y. Smoking status as a prognostic factor in patients with stage I pulmonary adenocarcinoma. Ann Thorac Surg 2006;81:1189 -1193.
40. Sakao Y, Miyamoto H, Oh S, et al. The impact of cigarette smoking on prognosis in small adenocarcinomas of the lung: the association between histologic subtype and smoking status. J Thorac Oncol 2008;3:958 -962.
41. Wynder EL, Muscat JE. The changing epidemiology of smoking and lung cancer histology. Environ Health Perspect 1995;103(Suppl. 8):143-148. 42.
42. Yano T, Miura N, Takenaka T, et al. Never-smoking non-small cell lung cancer as a separate entity: clinicopathologic features and survival. Cancer 2008;113:1012-1018.
43. Detterbeck FC, Gibson CJ. Turning gray: the natural history of lung cancer over time. J Thorac Oncol 2008;3:781-792.
44. Scagliotti GV, Parikh P, von Pawel J, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotheapynaive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008;26:3543-3551.
45. Einhorn LH. First-line chemotherapy for non-small-cell lung cancer: is there a superior regimen based on histology? J Clin Oncol 2008;26:3485-3486.